Shire: Takeda deadline looms, but will other bidders emerge for in-play £43bn drugs group?

11:07 EDT 20 Apr 2018 | Proactive Investors

Next week we'll see the colour of Takeda's money. Will rival bidders emerge from the woodwork?

More From BioPortfolio on "Shire: Takeda deadline looms, but will other bidders emerge for in-play £43bn drugs group?"